Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 1,170 INR
Change Today +2.65 / 0.23%
Volume 10.2K
As of 7:05 AM 10/13/15 All times are local (Market data is delayed by at least 15 minutes).

astrazeneca pharma india ltd (ASTR) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/16/15 - 1,299
52 Week Low
12/17/14 - 781.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

astrazeneca pharma india ltd (ASTR) Related Businessweek News

No Related Businessweek News Found

astrazeneca pharma india ltd (ASTR) Details

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. The company primarily offers products in the areas of cardiovascular and metabolic, gastrointestinal, infection, neuroscience, and oncology, as well as respiratory, inflammation, and autoimmunity diseases under the Crestor, Seloken XL, Meronem, Arimidex, Zoladex, Nexium, and Brilinta brands. It also provides clinical trial services on pharmaceutical products. The company was founded in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

1,654 Employees
Last Reported Date: 08/18/15
Founded in 1979

astrazeneca pharma india ltd (ASTR) Top Compensated Officers

Managing Director, Director, Member of Share ...
Total Annual Compensation: 13.5M
Chief Financial Officer
Total Annual Compensation: 8.0M
Compliance Officer, Legal Counsel and Company...
Total Annual Compensation: 3.0M
Compensation as of Fiscal Year 2015.

astrazeneca pharma india ltd (ASTR) Key Developments

AstraZeneca Pharma India Limited, Annual General Meeting, Sep 02, 2015

AstraZeneca Pharma India Limited, Annual General Meeting, Sep 02, 2015., at 11:00 Indian Standard Time. Location: Vivanta by Taj Hotel. Agenda: To receive, consider and adopt the financial statements - the Audited Balance Sheet as at March 31, 2015, the Audited Pro t & Loss Account and the Cash Flow Statement of the company and explanatory note annexed thereto or forming part of the above documents, for the financial year ended on that date and the reports of the directors and auditors thereon; to appoint a director in place of Mr. Ian Brimicombe who retires by rotation, and being eligible, offers himself for re-appointment; to appoint Messrs. BSR & Co. LLP, Chartered Accountants, as statutory auditors of the company to hold office from the conclusion of this meeting up to the conclusion of the next annual general meeting and to authorize the board of directors to fix their remuneration; and to consider other matters.

Astrazeneca Pharma India Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

AstraZeneca Pharma India Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported total income from operations (net) of INR 1,319.768 million compared to INR 1,256.428 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 10.034 million compared to loss of INR 193.932 million a year ago. Profit from ordinary activities before tax was INR 27.165 million compared to loss from ordinary activities before tax of INR 176.002 million a year ago. Net profit for the period was INR 27.165 million or INR 10.9 per basic and diluted share, compared to net loss INR 176.002 million or INR 7.04 per basic and diluted share, a year ago. Net sales /income from operations were INR 1,200.312 million compared to INR 1,255.726 million a year ago.

AstraZeneca Pharma India Limited to Report Q1, 2016 Results on Aug 04, 2015

AstraZeneca Pharma India Limited announced that they will report Q1, 2016 results on Aug 04, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ASTR:IN 1,170.45 INR +2.65

ASTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ASTR.
View Industry Companies

Industry Analysis


Industry Average

Valuation ASTR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.2x
Price/Book 19.0x
Price/Cash Flow 183.2x
TEV/Sales 6.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PHARMA INDIA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at